Results of cervical cancer trial hailed as 'biggest breakthrough for decades'

Findings from a CTC-led study into cervical cancer treatment have been published in the Lancet today, prompting further coverage for a trial [...]

Launch of the international SAFIR ABC10 program for patients with biliary tract cancer

Unicancer, University College of London (UCL) and the Belgian Group of Digestive Oncology (BGDO) announce the launch of the flagship SAFIR A [...]

Gynaecological Cancer Awareness Month in the UK

September marks Gynaecological Cancer Awareness Month in the UK, an annual campaign established by the Foundation for Women's Cancer (FWC) i [...]

(Publication) PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia.

Kothari J, Eyre T, Rismani A, Ediriwickrema K, Edwards D, Galani S, Wilson W, Lawrie A, Clifton-Hadley L, McCarthy H, Collins A, Lewis D, Ar [...]